Navigation Links
New Sub-Analysis of RE-LY Trial Examines Pradaxa in Patients with Atrial Fibrillation Undergoing Cardioversion
Date:1/5/2011

and bleeding similar to warfarin."

In the RE-LY trial, an imaging technique known as transesophageal echocardiography (TEE) was encouraged prior to cardioversion to identify existing clots in the left atrium of the heart, which would suggest an increased risk of stroke or embolism associated with cardioversion.(1)  TEE was performed prior to cardioversion in more patients on dabigatran 110mg and PRADAXA 150mg than warfarin (25.5%, 24.1%, 13.3%, respectively).(1)  Rates of stroke and systemic embolism were similar across all treatment arms for those who underwent TEE-guided cardioversions (0.61%, 0.00% and 1.14%, respectively; dabigatran 110mg vs. warfarin, p=0.65; PRADAXA 150mg vs. warfarin, p=0.17) and those who did not undergo TEE (0.83%, 0.39% and 0.52%, respectively; dabigatran 110mg vs. warfarin, p=0.54; PRADAXA 150mg vs. warfarin, p=0.75).(1)

"Physicians have expressed excitement about the recent approval of PRADAXA to reduce the risk of stroke for patients with atrial fibrillation," said Paul Reilly, PhD, clinical program director, Boehringer Ingelheim Pharmaceuticals, Inc.  "Boehringer Ingelheim remains committed to publishing data analyses from the RE-LY trial to help inform physicians about the clinical implications for patients taking PRADAXA."  

PRADAXA is the first oral anticoagulant to be approved in the U.S. in more than 50 years.  PRADAXA is now available in more than 35,000 pharmacies nationwide.  PRADAXA 75mg is also available for patients who have severe renal impairment.

About RE-LY®

RE-LY® was a global, Phase III, randomized trial of 18,113 patients(2) enrolled in 951 centers in 44 countries,(3) investigating whether PRADAXA (two blinded doses) was as effective as well-controlled warfarin – INR 2.0 - 3.0 – (open label) for stroke prevention.(2) Patients with NVAF and at least one other risk factor for stroke (i.e., previous ischemic stroke, transient
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New PLATO Sub-Analysis of CABG Patients Presented at ACC
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Data Published in The Lancet Compare Dabigatran Etexilate to Dose-Adjusted Warfarin Across RE-LY® Trial Centers
4. New Analyses of Data From RE-LY Trial, Involving Oral Anticoagulant Pradaxa, to be Presented at American Heart Associations Scientific Sessions
5. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
8. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
9. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: PharmaPoint: ... Market Analysis to 2022 ... - India Drug Forecast and Market Analysis ...
(Date:1/15/2014)...  A novel wearable injector slightly larger than an Oreo cookie ... self-inject prescription drugs in the large doses required to treat ... deficiencies, and genetic disorders.  An emerging biologic ... according to analysts.   Many of these drugs will require a ...
(Date:1/14/2014)... , Jan. 14, 2014 Dynamic Healthcare Services, Inc. ... today that it acquired Progressive Home Medical Equipment, Inc. ("Progressive") ... 2014. The terms of the acquisition were not disclosed. ... ("DME") company providing a wide range of sleep, mobility, and ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... May 11 The U.S. Food and Drug Administration recently approved ... 1g and 2g Cefepime for Injection USP and Dextrose Injection USP in ... , , ... , , ...
... HAYWARD, Calif. and Buffalo Grove, Ill. , May 11 ... Alma Lasers, Inc. today announced that they have reached an agreement resolving lawsuits ... , , ... in the U.S. District Court in Delaware by Alma Lasers ...
Cached Medicine Technology:FDA Approves Cefepime for Use In B. Braun's DUPLEX(R) System 2FDA Approves Cefepime for Use In B. Braun's DUPLEX(R) System 3Solta Medical and Alma Lasers Resolve Patent Lawsuits 2Solta Medical and Alma Lasers Resolve Patent Lawsuits 3
(Date:4/18/2014)... The Gerontologist reports that among ... a decrease in anxiety about death and increases in ... lives. In particular, listening to gospel music is associated ... increase in sense of control. , These associations are ... individuals of both low- and high-socioeconomic status. , The ...
(Date:4/18/2014)... University psychologists have made a brain-related discovery that ... disorders. , This discovery opens up the possibility ... suppress a specific brain activity that the researchers ... The Journal of Neuroscience has just ... McDonald, an associate professor of psychology and his ...
(Date:4/17/2014)... signs of chronic inflammation in non-cancerous prostate tissue may ... cancer than those with no inflammation, according to results ... Johns Hopkins Kimmel Cancer Center. , The link between ... with so-called high-grade prostate cancer those with a ... presence of the most aggressive and rapidly growing prostate ...
(Date:4/17/2014)... issue of Experimental Biology and Medicine ... Gaskins and Paul Kenis in the Institute of ... University of Illinois Urbana-Champaign describe their recent work ... a variety of cell functions including energy metabolism, ... roles in regulating normal cellular behavior, redox status ...
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
Breaking Medicine News(10 mins):Health News:Religious music brings benefit to seniors' mental health 2Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Building 'smart' cell-based therapies 2
... Will Educate Families And Increase Landlord ... ... Women and The Sherwin-Williams Company are pleased to announce "NOT,IN OUR ... arising from poor maintenance and neglect and to encourage property,owners and ...
... Sept. 10 Maxim Health Systems today,announced it will ... 2007. Maxim will provide flu shots nationwide through more,than ... http://www.FindAFluShot.com, helps users find a convenient location for,vaccination ... on the site to,obtain times and locations for clinics. ...
... DIEGO, Sept. 10 Conflict is an issue that ... to have little preparation on,how to communicate effectively to ... school bullies. These rivalries can be harmful,to children, whether ... violent behavior, and anger management issues. It is ...
... A lesser known,antibiotic-resistant bacteria is a growing ... are seeing the potentially deadly staph,infection known as ... South Texas was one of the first ... since become a hot bed for the infection. ...
... Breathe Act, MINNEAPOLIS, Sept. 10 Today ... to educate and excite Minnesotans about the,Freedom to ... into effect,on October 1. The new law will ... private clubs. Called Fresh Air, the,multimedia campaign is ...
... ... the Advancement of Science, PHILADELPHIA and LONDON, Sept. 10 ... ; TSX: TOC) and,leading provider of information solutions to the ... Laureates,-- researchers likely to be in contention for Nobel honors ...
Cached Medicine News:Health News:National Council of Negro Women (NCNW) Partners With Sherwin-Williams to Target Lead Risks in Neglected Housing 2Health News:Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide 2Health News:Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide 3Health News:Tips for Parents: Teaching Children to Resolve Conflicts 2Health News:South Texas Doctors Report More Severe Cases of Community Staph 'Super Bug' Hospitalizing Children 2Health News:Fresh Air Campaign to Showcase Minnesotans' Love of Smoke-Free Air 2Health News:Thomson Scientific Predicts Nobel Laureates 2Health News:Thomson Scientific Predicts Nobel Laureates 3Health News:Thomson Scientific Predicts Nobel Laureates 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: